Basic Information

Drug ID DDPD00987 ...
Drug Name Cytarabine
Molecular Weight 243.2166
Molecular Formula C9H13N3O5
CAS Number 147-94-4
SMILES NC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O
External Links
DRUGBANK DB00987
T3DB T3D4978
PubChem Compound 6253
PDR 1756
Drugs.com Drugs.com Drug Page

Experimental Physicochemical Property

Property Name Property Value Unit Raw Value Raw Unit Reference
Log P -2.8 - -2.8 - DRUGBANK
Melting Point 187.0 186-188 Hunter, J.H.; U S . Patent 3,116,282; December 31,1963; assigned to The Upjohn Company.

Pharmacokinetic/ Toxicokinetic Property

Property Name Property Value Unit Raw Value Raw Unit Annotation Reference
Absorption 20.0 % <20 % PO, oral; DRUGBANK
Bioavailability 20.0 % <20 % PO, oral; The Pharmacological Basis of Therapeutics
C Max 5000.0 ng/ml ~5 mcg/ml intravenous injection, IV; leukemia; malignant solid tumors; The Pharmacological Basis of Therapeutics
C Max 75.0 ng/ml 0.05-0.1 mcg/ml intravenous infusion, IV in drop; leukemia; malignant solid tumors; The Pharmacological Basis of Therapeutics
Clearance 0.78 L/h/kg 13±4 ml/min/kg The Pharmacological Basis of Therapeutics
Clearance 2.5 L/h/kg 41.67 ml/min/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Volume of Distribution 3.0 L/kg 3.0±11.9 L/kg The Pharmacological Basis of Therapeutics
Volume of Distribution 0.67 L/kg 0.67 L/kg intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Half-life 0.17 h 10 min DRUGBANK
Half-life 2.6 h 2.6±0.6 h The Pharmacological Basis of Therapeutics
Half-life 0.17 h 0.17 h intravenous injection, IV; human, homo sapiens; Human Intravenous Pharmacokinetic Dataset
Eliminate Route 11.0 % 11±8 % Urinary excretion; Unchanged drug; The Pharmacological Basis of Therapeutics
Protein Binding 13.0 % 13 % DRUGBANK
Protein Binding 13.0 % 13 % The Pharmacological Basis of Therapeutics

Maximum Dosage

Property Name Property Value Unit Raw Value Raw Unit Annotation Brand Name Component Reference
Max dose for adults 50.0 mg/dose 50 mg/dose intrathecal administration DepoCyt cytarabine liposome PDR
Max dose for elderly 50.0 mg/dose 50 mg/dose intrathecal administration DepoCyt cytarabine liposome PDR

Drug Property Radar Chart

...

Note: Center: Q1-1.5*IQR, Edge: Q3+1.5*IQR; Q1: Quantile 1, Q3: Quantile 3, IQR: Q3-Q1